Shanghai Argo Biopharmaceutical Co., Ltd.

This study tests a new injectable drug (BW-20507) combined with pegylated interferon in 209 adults with chronic hepatitis B. The goal is to see if this combination can lower hepatitis B virus markers enough to let patients safely stop their daily antiviral medication. Participant…

This study tests an experimental drug called BW-00112 in 145 adults with mixed dyslipidemia, a condition where blood fats like cholesterol and triglycerides are too high. Participants receive either the drug or a placebo as a shot under the skin, while continuing their usual stat…

This study tests a new medicine called BW-20805 in 25 adults with hereditary angioedema (HAE), a condition that causes sudden, painful swelling attacks. The goal is to see if the drug can reduce how often these attacks happen over about 6 months. Participants receive the drug and…